# SODIUM NITROPRUSSIDE
> **ANDA214199** · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2020-08-25
## Drug
- **FDA Application Number:** ANDA214199
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SODIUM NITROPRUSSIDE
- **Generic name:** SODIUM NITROPRUSSIDE
- **Active ingredients:** SODIUM NITROPRUSSIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** SLATE RUN PHARMA
- **Manufacturer:** Hainan Poly Pharm. Co., Ltd.
- **First approval:** 2020-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214199)
---
*AI Analytics · CC0 1.0*